title: Endometriosis associated with relapsing ascites and pleural effusions.
authors.affiliation: Department of Obstetrics and Gynecology.
authors.forename: P S
authors.initials: PS
authors.lastname: Hasdemir
authors.forename: N
authors.initials: N
authors.lastname: Ikiz
authors.forename: H T
authors.initials: HT
authors.lastname: Ozcakir
authors.forename: E
authors.initials: E
authors.lastname: Kara
authors.forename: T
authors.initials: T
authors.lastname: Guvenal
mesh_terms: D000328:Adult; D001201:Ascites / Q000209:etiology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D004715:Endometriosis / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D005260:Female; D006727:Hormone Antagonists / Q000008:administration & dosage; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage*; D009277:Nandrolone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D010048:Ovarian Cysts / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D019152:Paracentesis / Q000379:methods*; D010529:Peritoneal Cavity / Q000000981:diagnostic imaging / Q000473:pathology; D010994:Pleura / Q000473:pathology*; D010996:Pleural Effusion / Q000209:etiology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D006727:Hormone Antagonists; C023635:dienogest; D009277:Nandrolone; D016729:Leuprolide